Mml Investors Services, LLC Neurocrine Biosciences Inc Transaction History

Mml Investors Services, LLC

  • $27.4 Billion
  • Q3 2024

A detailed history of Mml Investors Services, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Mml Investors Services, LLC holds 9,833 shares of NBIX stock, worth $1.34 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,833
Previous 9,962 1.29%
Holding current value
$1.34 Million
Previous $1.37 Million 17.36%
% of portfolio
0.0%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024
SELL
$114.58 - $153.15 $14,780 - $19,756
-129 Reduced 1.29%
9,833 $1.13 Million
Q2 2024

Aug 14, 2024
SELL
$130.86 - $143.19 $9,683 - $10,596
-74 Reduced 0.74%
9,962 $1.37 Million
Q1 2024

May 14, 2024
BUY
$130.4 - $143.74 $359,382 - $396,147
2,756 Added 37.86%
10,036 $1.38 Million
Q4 2023

Feb 14, 2024
BUY
$106.07 - $132.76 $128,875 - $161,303
1,215 Added 20.03%
7,280 $959,000
Q3 2023

Nov 14, 2023
BUY
$94.02 - $117.1 $10,060 - $12,529
107 Added 1.8%
6,065 $682,000
Q2 2023

Aug 14, 2023
SELL
$89.53 - $104.87 $85,411 - $100,045
-954 Reduced 13.8%
5,958 $562,000
Q1 2023

May 12, 2023
SELL
$94.11 - $123.02 $131,001 - $171,243
-1,392 Reduced 16.76%
6,912 $700,000
Q4 2022

Feb 13, 2023
BUY
$106.72 - $127.06 $129,344 - $153,996
1,212 Added 17.09%
8,304 $992,000
Q3 2022

Nov 14, 2022
BUY
$92.03 - $107.81 $11,319 - $13,260
123 Added 1.76%
7,092 $753,000
Q2 2022

Aug 12, 2022
BUY
$75.79 - $100.07 $24,177 - $31,922
319 Added 4.8%
6,969 $679,000
Q1 2022

May 13, 2022
BUY
$72.45 - $94.81 $140,842 - $184,310
1,944 Added 41.31%
6,650 $623,000
Q4 2021

Feb 14, 2022
SELL
$79.65 - $106.22 $298,846 - $398,537
-3,752 Reduced 44.36%
4,706 $401,000
Q3 2021

Nov 15, 2021
SELL
$86.18 - $99.03 $11,720 - $13,468
-136 Reduced 1.58%
8,458 $811,000
Q2 2021

Aug 13, 2021
BUY
$89.43 - $102.27 $171,526 - $196,153
1,918 Added 28.73%
8,594 $836,000
Q1 2021

May 14, 2021
BUY
$87.57 - $119.4 $17,951 - $24,477
205 Added 3.17%
6,676 $649,000
Q4 2020

Feb 12, 2021
SELL
$86.91 - $108.33 $137,143 - $170,944
-1,578 Reduced 19.6%
6,471 $620,000
Q3 2020

Nov 13, 2020
BUY
$96.16 - $135.15 $468,587 - $658,585
4,873 Added 153.43%
8,049 $774,000
Q2 2020

Aug 14, 2020
BUY
$85.09 - $130.36 $270,245 - $414,023
3,176 New
3,176 $387,000
Q1 2020

May 14, 2020
SELL
$75.11 - $113.76 $146,689 - $222,173
-1,953 Closed
0 $0
Q4 2019

Feb 11, 2020
BUY
$86.8 - $118.57 $169,520 - $231,567
1,953 New
1,953 $210,000

Others Institutions Holding NBIX

# of Institutions
626
Shares Held
94M
Call Options Held
632K
Put Options Held
621K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.1B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Mml Investors Services, LLC Portfolio

Follow Mml Investors Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mml Investors Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email